-
Clinical Experience with Actinium-PSMA Across Multiple Treatment Centers "Presentation" - Alfred Morgenstern
19 Apr 2025 05:43 GMT
… then shortly after, I started treating the first patients with Clemens … didn’t have any treatment discontinuation due to xerostomia.
So I think … actinium-labeled radiopharmaceuticals are under development. We are still facing a …
-
Navigating medication risks in elderly patients: Essential tips for dental hygienists
19 Apr 2025 08:10 GMT
… assessments. When treating older patients, understanding how medications interact is … quickly assess drug interactions and adjust treatment plans accordingly. … SSRIs, and SNRIs (antidepressant medications), cause xerostomia, which increases the risk …
-
Perspectives on Talquetamab and its Utility in the Treatment of Multiple Myeloma: Safety, Efficacy and Place in Therapy
02 Apr 2025 16:43 GMT
… novel classes of drugs, most patients develop therapeutic resistance … the Food and Drug Administration (FDA) for use in … discontinued treatment due to xerostomia. Common medications employed to manage xerostomia … 2 MagnetisMM-3 trial results. Nat Med. 2023;29( …
-
The next generation of toothpaste for xerostomia patients
27 Mar 2025 16:28 GMT
… listing one or more medications with xerostomia as a side effect … much higher risk of developing dental caries. This is … what the Food and Drug Administration (FDA) deems safe for over … most biocompatible ingredients ever developed. This material comprises 97% …
-
Citrus remedy squeezes out dry mouth for cancer patients
24 Mar 2025 10:18 GMT
… effective without significant side effects.
Developed by the University of South … a lipid-based drug delivery system to treat dry mouth (xerostomia), a common … undergoing radiotherapy and other medical treatments regularly experience dry mouth, which …
-
RNA Therapies Clinical Trials And Pipeline 2025: EMA, PDMA, FDA Approvals, Medication, IND, NDA Approval, Therapies, Mechanism Of Action, Route Of Administration And Companies By Delveinsight
18 Mar 2025 01:53 GMT
… ;2a Trial in Radiation-Induced Xerostomia and … effective in treating rare genetic … FDA for RGT-61159, which is being developed for the potential treatment … Pharmaceuticals, Arbutus Biopharm, Dicerna Pharmaceuticals, Inc., SanegeneBio, Alnylam Pharmaceuticals, …
-
Gene Therapy Biotech MeiraGTx Strikes Deal Bringing Generative AI to Pivotal Parkinson’s Trial
14 Mar 2025 21:47 GMT
… deep brain stimulation to treat Parkinson’s. Delivery of … of trial success.
MeiraGTx will lead clinical development of … radiation-induced xerostomia — dry mouth caused when radiation treatment for … effect has no approved drug therapy, though frequent sips …
-
MeiraGTx Enters into a Strategic Collaboration with Hologen AI to Expedite Phase 3 Development of AAV-GAD for Parkinson’s Disease and Industrialize MeiraGTx’s Proprietary Manufacturing Process
13 Mar 2025 11:30 GMT
… response to AAV-GAD treatment.” Dr. Forbes continued, … disease and radiation-induced xerostomia. MeiraGTx uses its … for clinical medicine and pharmaceutical drug development. Hologen builds the … used to increase trial success probabilities substantially …
-
Pharmacist-Led Research Highlights Key Insights and Innovations in Patient Care
11 Mar 2025 16:14 GMT
… complexity of treatments and patient care seen across health systems, pharmacists continue … conditions such as xerostomia (dry mouth), the importance of medication education, and …
-
Anxiety and Sun Exposure as Triggers for Herpes Labialis: A Case Report and Review of Literature
24 Apr 2025 16:10 GMT
… out using pharmacologic and non-pharmacologic therapies. Pharmacological treatments such as … reasons. He took his medication as instructed. The … responses associated with developing HL.43 Localized … I. The improvement of xerostomia and reduction of anxiety …